2018
DOI: 10.1080/00498254.2018.1480818
|View full text |Cite
|
Sign up to set email alerts
|

Bisphenol S modulates concentrations of bisphenol A and oestradiol in female and male mice

Abstract: Concern over endocrine-disrupting actions of bisphenol A (BPA) has prompted some manufacturers to remove it from consumer products. Among the chemical replacements in "BPA-free" products are other bisphenol analogues, such as bisphenol S (BPS). Given evidence that BPA and BPS possess similar oestrogenic activity, their capacity to interact and disrupt oestrogen homeostasis should be examined. We investigated whether BPS can modulate concentrations of C-BPA, exogenousH-oestradiol (E2), or natural E2. CF-1 mice … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 73 publications
0
6
0
Order By: Relevance
“…However, the similar BPA toxicokinetic results obtained in this study compared to previous work (Volkel et al, 2002;Doerge et al, 2010;Gayrard et al, 2013;Patterson et al, 2013;Thayer et al, 2015) suggest that co-exposure to other bisphenols did not interfere with BPF or BPA kinetics. Although, a recent study has demonstrated that the co-administration of BPA (oral, 50 µg/kg C 14 -BPA) with BPS (s.c. injections, 1, 3, 6, and 9 mg) results in elevated circulating levels of total BPA in mice at the 9 mg BPS dose (Pollock et al, 2018) and hypothesized that the BPA kinetics may be altered due to competition for metabolic enzymes, such as sulfotransferase (SULT) or UDP-glucuronosyltransferase (UGT) (Pollock et al, 2018).…”
Section: Maternal Toxicokinetics Of Bisphenolsmentioning
confidence: 99%
“…However, the similar BPA toxicokinetic results obtained in this study compared to previous work (Volkel et al, 2002;Doerge et al, 2010;Gayrard et al, 2013;Patterson et al, 2013;Thayer et al, 2015) suggest that co-exposure to other bisphenols did not interfere with BPF or BPA kinetics. Although, a recent study has demonstrated that the co-administration of BPA (oral, 50 µg/kg C 14 -BPA) with BPS (s.c. injections, 1, 3, 6, and 9 mg) results in elevated circulating levels of total BPA in mice at the 9 mg BPS dose (Pollock et al, 2018) and hypothesized that the BPA kinetics may be altered due to competition for metabolic enzymes, such as sulfotransferase (SULT) or UDP-glucuronosyltransferase (UGT) (Pollock et al, 2018).…”
Section: Maternal Toxicokinetics Of Bisphenolsmentioning
confidence: 99%
“…The comprehensive work of T. Pollock and his colleagues produced valuable results, describing cross talk of common EDs. The combined presence of bisphenols is considered to be deleterious [95] as well as the simultaneous presence of triclosan, a soap compound [96,97]. Degradation of bisphenol is inhibited under other ED exposure, and, obviously, the co-exposure achieves various modes on how to affect the body [98].…”
Section: Molecular Mechanism Of Eds In Extremely Low Dosesmentioning
confidence: 99%
“…Even a low dose of chronic exposure to bisphenols suppresses the luteinizing hormone, follicle-stimulating hormones, and prolactin, exhibiting estrogenic and antiandrogenic effects and affecting spermatogenesis [12,47,48]. Common reproductive abnormalities include premature puberty, ovarian dysfunction, implantation failure, abnormal sperm function, fertilization failure, sex hormone abnormality, premature birth, and lower birth weight [48][49][50][51][52]. Bisphenols interact with both membrane-bound and nuclear estrogen receptors.…”
Section: Endocrine Disruption and Reproductive Abnormalitiesmentioning
confidence: 99%